Comparable stake leader
Andrew Smith-Van Vurst
SEC ownership of BioStem Technologies, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001658678.
Disclosed value leader
—
Comparable rows
0/7
Latest evidence
11 Aug 2026
- Public ticker
- BSEM on OTC
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Andrew Smith-Van Vurst
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
11 Aug 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001658678
- Issuer location
- Pompano Beach, FL
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of BioStem Technologies, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Andrew Smith-Van Vurst
Disclosed value leader
—
Comparable rows
0/7
Latest evidence
11 Aug 2026
3/4/5
Some rows are evidence-backed but not safely comparable across classes.
7 rows are not safely comparable across share classes.
Quick read
SEC ownership evidence is available, but the rows are not safely comparable across share classes.
0 of 7 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Andrew Smith-Van Vurst's linked filing trail.
Detailed SEC evidence table Showing 1-7 of 7 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Andrew Smith-Van Vurst |
3/4/5
Chief Operating Officer, Director, 10%+ Owner
|
—
class O/S missing
|
—
1,522,613 shares
|
— | 06 Aug 2026 |
| Jason Matuszewski |
3/4/5
Chief Executive Officer, Director, 10%+ Owner
|
—
class O/S missing
|
—
1,278,433 shares
|
— | 06 Aug 2026 |
| Brandon Poe |
3/4/5
Chief Financial Officer
|
—
mixed-class rows
|
—
195,360 shares
mixed-class rows
|
— | 11 Aug 2026 |
| Michael A. Fortunato |
3/4/5
Chief Accounting Officer
|
—
mixed-class rows
|
—
109,766 shares
mixed-class rows
|
— | 09 Aug 2026 |
| Kenneth Howard Warrington Jr. |
3/4/5
Director
|
—
class O/S missing
|
—
27,140 shares
|
— | 06 Aug 2026 |
| Jodi Ungrodt |
3/4/5
Director
|
—
class O/S missing
|
—
5,648 shares
|
— | 06 Aug 2026 |
| Barry Hassett |
3/4/5
Chief Commercial Officer
|
—
class O/S missing
|
—
4,503 shares
|
— | 06 Aug 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 21 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-11 of 11 reporting-owner rows connected to BioStem Technologies, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
11
Largest Forms 3/4/5 holder
Mark A. Glickman
Net 12M change
$0
Latest report
11 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Mark A. Glickman | Director | Mixed | 06 Aug 2026 | |||
| Jason Matuszewski | Chief Executive Officer, Director, 10%+ Owner | Mixed | 06 Aug 2026 | |||
| Rayna Lesser Hannaway | Director | Mixed | 06 Aug 2026 | |||
| Brandon Poe | Chief Financial Officer | Mixed | 11 Aug 2026 | |||
| Andrew Smith-Van Vurst | Chief Operating Officer, Director, 10%+ Owner | Mixed | 06 Aug 2026 | |||
| Kenneth Howard Warrington Jr. | Director | Mixed | 06 Aug 2026 | |||
| Katherine Gorrell | Clco | Mixed | 06 Aug 2026 | |||
| Michael A. Fortunato | Chief Accounting Officer | Mixed | 09 Aug 2026 | |||
| Barry Hassett | Chief Commercial Officer | Mixed | 06 Aug 2026 | |||
| Steven D. Sonenreich | Director | Mixed | 06 Aug 2026 | |||
| Jodi Ungrodt | Director | Mixed | 06 Aug 2026 |
Recent insider transactions for BioStem Technologies, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Brandon Poe | BSEM | Common Stock | Options Exercise | 23.2% | 10,634 | 56,368 | 11 Aug 2026 | Direct | ||
| Brandon Poe | BSEM | Restricted Stock Units | Options Exercise | -33% | -10,634 | 21,591 | 11 Aug 2026 | Direct | ||
| Michael A. Fortunato | BSEM | Common Stock | Options Exercise | 1.53% | 970 | 64,430 | 09 Aug 2026 | Direct | ||
| Michael A. Fortunato | BSEM | Restricted Stock Units | Options Exercise | -12.5% | -970 | 6,790 | 09 Aug 2026 | Direct |
* marks a reported price that did not pass the local price check.